Can a blood test predict who benefits from brain surgery for Parkinson's?

NCT ID NCT07376278

Recruiting now Knowledge-focused Sponsor: Hong Kong University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking for clues in the blood that might tell doctors ahead of time whether deep brain stimulation (DBS) surgery will work well for a person with Parkinson's disease. Researchers will collect blood and leftover brain tissue from 30 people who are already scheduled for DBS. They will measure proteins and RNA in the blood and compare them to standard Parkinson's rating scales to see if any markers predict good or poor outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors predict which Parkinson's patients will benefit most from deep brain stimulation surgery.
What could go wrong: This is a small observational study, not a treatment trial. It may not find reliable predictors, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP BRAIN STIMULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEEP BRAIN STIMULATION PARKINSON DISEASE (DISORDER)

Contacts and locations

Locations

The Hong Kong University of Science and Technology
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.